10th July 12.00 – 13.30 via ON24.
Following recent changes to the National Test Directory to the breast genetic testing pathway, this webinar will provide an opportunity for the breast clinical community to:
- Understand recent changes to the National Test Directory and associated changes to the GM Cancer Breast Cancer Genetic Testing Toolkit
- Recap the role of genomic pathways for breast cancer patients that are approved within the National Test Directory
- Explore the development of a testing pathway for patients with metastatic breast cancer
Learning Objectives
- Understand recent updates to the National Genomic Test Directory and their implications for breast cancer genetic testing pathways. Including changes to eligibility criteria, test access, and pathway considerations across inherited and somatic testing.
- Recap the role of genomic testing within breast cancer care pathways. Including an overview of germline and tumour testing, key genomic markers, and how genomic results influence treatment decisions, risk assessment and family management.
- Explore considerations for developing an effective genomic testing pathway for patients with metastatic breast cancer
Including pathway design, clinical eligibility, MDT integration, operational challenges, and opportunities to improve timely access to targeted therapies.
You must be logged in to register for this event.
